Cargando…

Estramustine Phosphate Inhibits TGF-β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production

Transforming growth factor-beta (TGF-β) has been demonstrated as a key regulator of immune responses including monocyte/macrophage functions. TGF-β regulates macrophage cell migration and polarization, as well as it is shown to modulate macrophage urokinase-type plasminogen activator (uPA) productio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mojsilovic, Sonja S., Mojsilovic, Slavko, Bjelica, Suncica, Santibanez, Juan F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139214/ https://www.ncbi.nlm.nih.gov/pubmed/30245956 http://dx.doi.org/10.1155/2018/3134102

Ejemplares similares

The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
por: Mojsilovic, Sonja S., et al.
Publicado: (2021)

Regulation of the mesenchymal stem cell fate by interleukin-17: Implications in osteogenic differentiation
por: Krstić, Jelena, et al.
Publicado: (2021)

Myeloid-Derived Suppressor Cells in Hematologic Diseases: Promising Biomarkers and Treatment Targets
por: Bizymi, Nikoleta, et al.
Publicado: (2019)

Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression
por: Krstić, Jelena, et al.
Publicado: (2015)

Interleukin-17 and Its Implication in the Regulation of Differentiation and Function of Hematopoietic and Mesenchymal Stem Cells
por: Mojsilović, Slavko, et al.
Publicado: (2015)

Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse
Publicado: (1984)

Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines.
por: von Schoultz, E., et al.
Publicado: (1988)

Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
por: Bergenheim, A. T., et al.
Publicado: (1993)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Editorial: Microenvironment-Derived Stem Cell Plasticity
por: Krstic, Jelena, et al.
Publicado: (2017)

Editorial: Microenvironment-derived stem cell plasticity—volume II
por: Gadjanski, Ivana, et al.
Publicado: (2022)

The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation
por: Trivanović, Drenka, et al.
Publicado: (2016)

Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells
Publicado: (1987)

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience
por: Nakano, Kazuhiko, et al.
Publicado: (2012)

Marked leukocytosis in response to estramustine phosphate in a hormone-refractory prostate cancer patient
por: Morita, Tatsuo
Publicado: (2010)

Exogenous Urokinase Inhibits Proteasomal Degradation of Its Cognate Urokinase Plasminogen Activator Receptor
por: Zhu, Ran, et al.
Publicado: (2022)

Transforming Growth Factor-Beta and Urokinase-Type Plasminogen Activator: Dangerous Partners in Tumorigenesis—Implications in Skin Cancer
por: Santibanez, Juan F.
Publicado: (2013)

Epirubicin combined with estramustine phosphate in hormone-resistant prostate cancer: a phase II study.
por: Hernes, E. H., et al.
Publicado: (1997)

Macrophages Provide Essential Support for Erythropoiesis, and Extracellular ATP Contributes to a Erythropoiesis-Supportive Microenvironment during Repeated Psychological Stress
por: Momčilović, Sanja, et al.
Publicado: (2023)

Doxycycline Inhibits IL-17-Stimulated MMP-9 Expression by Downregulating ERK1/2 Activation: Implications in Myogenic Differentiation
por: Obradović, Hristina, et al.
Publicado: (2016)

In silico docking of urokinase plasminogen activator and integrins
por: Degryse, Bernard, et al.
Publicado: (2008)

Effects of radiotherapy and estramustine on the microvasculature in malignant glioma
por: Johansson, M, et al.
Publicado: (1999)

Shear stress modulates macrophage-induced urokinase plasminogen activator expression in human chondrocytes
por: Yeh, Chih-Chang, et al.
Publicado: (2013)

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer
por: Naitoh, Hiroyuki, et al.
Publicado: (1995)

Reduced Expression of Urokinase Plasminogen Activator in Brown Adipose Tissue of Obese Mouse Models
por: Wu, Chung-Ze, et al.
Publicado: (2021)

Urokinase Plasminogen Activator Induces Pro-Fibrotic/M2 Phenotype in Murine Cardiac Macrophages
por: Meznarich, Jessica, et al.
Publicado: (2013)

Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review
por: Manzo, Paola, et al.
Publicado: (2023)

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors
Publicado: (1987)

Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis
por: Lee, Ji-Hye, et al.
Publicado: (2014)

Inflammatory niche: Mesenchymal stromal cell priming by soluble mediators
por: Jauković, Aleksandra, et al.
Publicado: (2020)

High-Risk Human Papillomavirus in Patients with Oral Carcinoma and Oral Potentially Malignant Disorders in Serbia—A Pilot Study
por: Petrović, Anđelija, et al.
Publicado: (2023)

The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type
Publicado: (1986)

Plasminogen Activator Inhibitor-1 Protects Mice Against Cardiac Fibrosis by Inhibiting Urokinase-type Plasminogen Activator-mediated Plasminogen Activation
por: Gupta, Kamlesh K., et al.
Publicado: (2017)

Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer
por: Albrecht, W, et al.
Publicado: (2004)

Uncharged isocoumarin-based inhibitors of urokinase-type plasminogen activator
por: Heynekamp, Justin J, et al.
Publicado: (2006)

Overexpression of urokinase-type plasminogen activator in pterygia and pterygium fibroblasts
por: Chao, Shih-Chun, et al.
Publicado: (2011)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma
por: Ierodiakonou, Despo, et al.
Publicado: (2016)

Urokinase-type Plasminogen Activator Induces Neurorepair in the Ischemic Brain
por: Merino, Paola, et al.
Publicado: (2018)

Inhibition of urokinase-type plasminogen activator expression by dihydroartemisinin in breast cancer cells
por: ZHANG, SHUQUN, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e2nlp8cc2a97qcpo4nug65bmvk